$7.81B
$2.45 Million
0.0% of portfolio
14,053
Q4 2023
New
$14.7B
$1.47 Million
0.0% of portfolio
32,933
Q4 2023
Reduced 52.54%
-
$0
0.0% of portfolio
-
Q4 2023
Added 22.54%
$98.8B
$339,000
0.0% of portfolio
3,983
Q2 2023
Added 1.53%
$18.8B
$3.26 Million
0.0% of portfolio
24,238
Q4 2023
Reduced 0.51%
$893M
$1.84 Million
0.0% of portfolio
165,619
Q4 2023
Added 12.42%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 0.57%
$2.39B
$466,000
0.0% of portfolio
6,547
Q4 2023
Added 5.78%
$1.45B
$3.16 Million
0.0% of portfolio
107,005
Q4 2023
New
$6.63B
$2.43 Million
0.0% of portfolio
40,784
Q4 2023
Reduced 13.3%
$1.45B
$362,000
0.0% of portfolio
5,241
Q4 2023
New
$19.1B
$3.26 Million
0.0% of portfolio
7,980
Q4 2023
Reduced 23.11%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 0.93%
$27B
$3.44 Million
0.0% of portfolio
59,723
Q4 2023
New
$90.6B
$222,000
0.0% of portfolio
570
Q4 2023
New
$8.83B
$3.28 Million
0.0% of portfolio
91,914
Q4 2023
New
$120M
$3.55 Million
0.0% of portfolio
379,960
Q4 2023
Reduced 22.49%
$73.9B
$3.34 Million
0.0% of portfolio
10,674
Q4 2023
Reduced 2.47%
$6.52B
$2.45 Million
0.0% of portfolio
37,668
Q4 2023
Reduced 13.8%
$4.19B
$415,000
0.0% of portfolio
8,814
Q4 2023
Reduced 65.25%
$5.6B
$363,000
0.0% of portfolio
8,517
Q4 2023
New
$1.7B
$407,000
0.0% of portfolio
2,819
Q4 2023
Reduced 35.2%
$646M
$470,000
0.0% of portfolio
5,766
Q4 2023
Reduced 2.93%
$36.5B
$3.31 Million
0.0% of portfolio
56,918
Q4 2023
Reduced 2.7%
$1.59B
$433,000
0.0% of portfolio
11,652
Q4 2023
Reduced 3.0%
$5.52B
$239,000
0.0% of portfolio
4,773
Q4 2023
Reduced 95.04%
$3.72B
$1.14 Million
0.0% of portfolio
20,417
Q4 2023
Added 6.89%
$2.19B
$2.02 Million
0.0% of portfolio
108,676
Q4 2023
Reduced 4.74%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 24.16%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 10.05%
$2.16B
$3.22 Million
0.0% of portfolio
204,446
Q4 2023
Reduced 22.5%
$26.6B
$3.26 Million
0.0% of portfolio
36,959
Q4 2023
Added 53.55%
$51.8B
$324,000
0.0% of portfolio
3,479
Q4 2023
Added 3.85%
$1.51B
$368,000
0.0% of portfolio
16,774
Q4 2023
Added 20.07%
Neurocrine Biosciences Inc
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 54.11%
$207M
$363,000
0.0% of portfolio
16,898
Q4 2023
Reduced 8.67%
$4.59B
$575,000
0.0% of portfolio
12,920
Q4 2023
Added 3.37%
$5.47B
$2.74 Million
0.0% of portfolio
5,028
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
Added 0.33%
$287M
$2.98 Million
0.0% of portfolio
216,158
Q4 2023
Reduced 3.22%
$1.17B
$380,000
0.0% of portfolio
11,055
Q4 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
Added 4.85%
$490M
$343,000
0.0% of portfolio
25,477
Q4 2023
Reduced 3.05%
$3.52B
$374,000
0.0% of portfolio
12,607
Q4 2023
Reduced 3.02%
$8.41B
$3.63 Million
0.0% of portfolio
84,328
Q4 2023
Reduced 59.91%
$24B
$962,000
0.0% of portfolio
281,513
Q4 2023
Reduced 3.99%
-
$0
0.0% of portfolio
-
Q4 2023
New
$408M
$2.29 Million
0.0% of portfolio
40,010
Q4 2023
Reduced 1.48%
$1.39B
$824,000
0.0% of portfolio
21,181
Q4 2023
Reduced 3.06%
$979M
$339,000
0.0% of portfolio
70,712
Q4 2023
Reduced 64.22%